Philips Healthcare

Royal Philips (NYSE: PHG, AEX: PHIA) is a leading health technology company founded in 1891 in the Netherlands by Frederik and Gerard Philips. Originally a lighting and consumer electronics firm, Philips has transformed into one of the world's foremost medical technology companies, headquartered in Best, Netherlands and Andover, Massachusetts, with approximately 69,700 employees operating in over 100 countries.

The company operates across three business segments: Diagnosis & Treatment (nearly 50% of revenue, covering CT scanners, MRI systems, ultrasound, X-ray, and image-guided therapy), Connected Care (hospital monitoring, analytics, informatics, and sleep and respiratory care), and Personal Health (oral care and grooming products). In FY 2024, Philips reported total sales of €18.0 billion with an 11.5% Adjusted EBITA margin.

Philips' stated purpose is to improve people's health and well-being through meaningful innovation, with a goal of improving 2.5 billion lives per year by 2030, including 400 million in underserved communities. The company has made notable sustainability strides, achieving 100% EcoDesigned new product introductions in 2024 and generating 24% of total sales from circular economy revenues. Its next-generation BlueSeal helium-free MRI system is now installed in more than 1,500 locations worldwide.

As a major player in diagnostic imaging, connected hospital care, and health informatics, Philips sits at the intersection of hardware, software, and data analytics in healthcare — making innovations in AI-driven diagnostics, remote monitoring, and sustainable medical devices directly relevant to its core business strategy.